Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs for the treatment of various cancers. The company is involved in the research, production, marketing, promotion, and sale of medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids under the Antineoplastons trade name. It also offers consulting services. The company was founded in 1977 and is headquartered in Houston, Texas.
Subscribe to see BURZYNSKI RESEARCH INSTITUTE INC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BURZYNSKI RESEARCH INSTITUTE INC is a biotech company headquartered in Houston, United States. It is publicly listed (BZYR) with a market capitalisation of $262,896. Xcout tracks 10 named people at BURZYNSKI RESEARCH INSTITUTE INC, including Stanislaw R. Burzynski (President, CFO, Company Secretary, Principal Finance & Accounting Officer, CEO and Chairman).
4 more named people on record for BURZYNSKI RESEARCH INSTITUTE INC, with roles, board committees and tenure — see the full roster →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.